Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients

Ernesto P. Molmenti, George J. Netto, Natalie G. Murray, Douglas M. Smith, Hebe Molmenti, Jeffrey S. Crippin, Tyrone C. Hoover, Ghapjoong Jung, Shigeru Marubashi, Edmund Q. Sanchez, Brian Gogel, Marlon F. Levy, Robert M. Goldstein, Carlos G. Fasola, Thomas A. Gonwa, Goran B. Klintmalm

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

We prospectively collected data on 1,429 liver transplant recipients between December 1984 and December 1998. Fifty-five patients (3.8%; 10 men, 45 women; median age, 44.5 ± 13 [SD] years) with autoimmune hepatitis (AIH) underwent orthotopic liver transplantation (OLT). Transplant recipients with AIH were younger, more likely to be women, and had a greater likelihood of rejection in the first 3, 6, and 12 months. There was no difference in patient survival or graft survival. There were 11 biopsy-proven recurrences (1 man, 10 women) of AIH after OLT. Almost half the episodes occurred within the first year after OLT. No patient required re-OLT because of recurrent disease. AIH has an incidence of 4% and a recurrence rate of 20% in OLT. Transplant recipients are more likely to be young women and have an increased incidence of acute cellular rejection (ACR) during the first post-OLT year. Recurrence should be suspected in those with abnormal liver function test results in the absence of ACR, especially during the first year after OLT. We cannot establish with certainty whether the observed process represents recurrence of the original autoimmune disease, an alloimmune phenomenon, or allograft dysfunction mimicking AIH.

Original languageEnglish (US)
Pages (from-to)519-526
Number of pages8
JournalLiver Transplantation
Volume8
Issue number6
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Autoimmune Hepatitis
Liver Transplantation
Recurrence
Liver
Incidence
Liver Function Tests
Graft Survival
Transplant Recipients
Autoimmune Diseases
Allografts
Biopsy
Survival

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Molmenti, E. P., Netto, G. J., Murray, N. G., Smith, D. M., Molmenti, H., Crippin, J. S., ... Klintmalm, G. B. (2002). Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. Liver Transplantation, 8(6), 519-526. https://doi.org/10.1053/jlts.2002.32981

Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. / Molmenti, Ernesto P.; Netto, George J.; Murray, Natalie G.; Smith, Douglas M.; Molmenti, Hebe; Crippin, Jeffrey S.; Hoover, Tyrone C.; Jung, Ghapjoong; Marubashi, Shigeru; Sanchez, Edmund Q.; Gogel, Brian; Levy, Marlon F.; Goldstein, Robert M.; Fasola, Carlos G.; Gonwa, Thomas A.; Klintmalm, Goran B.

In: Liver Transplantation, Vol. 8, No. 6, 2002, p. 519-526.

Research output: Contribution to journalArticle

Molmenti, EP, Netto, GJ, Murray, NG, Smith, DM, Molmenti, H, Crippin, JS, Hoover, TC, Jung, G, Marubashi, S, Sanchez, EQ, Gogel, B, Levy, MF, Goldstein, RM, Fasola, CG, Gonwa, TA & Klintmalm, GB 2002, 'Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients', Liver Transplantation, vol. 8, no. 6, pp. 519-526. https://doi.org/10.1053/jlts.2002.32981
Molmenti, Ernesto P. ; Netto, George J. ; Murray, Natalie G. ; Smith, Douglas M. ; Molmenti, Hebe ; Crippin, Jeffrey S. ; Hoover, Tyrone C. ; Jung, Ghapjoong ; Marubashi, Shigeru ; Sanchez, Edmund Q. ; Gogel, Brian ; Levy, Marlon F. ; Goldstein, Robert M. ; Fasola, Carlos G. ; Gonwa, Thomas A. ; Klintmalm, Goran B. / Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. In: Liver Transplantation. 2002 ; Vol. 8, No. 6. pp. 519-526.
@article{2b155688274f473a97295ea8749daf7e,
title = "Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients",
abstract = "We prospectively collected data on 1,429 liver transplant recipients between December 1984 and December 1998. Fifty-five patients (3.8{\%}; 10 men, 45 women; median age, 44.5 ± 13 [SD] years) with autoimmune hepatitis (AIH) underwent orthotopic liver transplantation (OLT). Transplant recipients with AIH were younger, more likely to be women, and had a greater likelihood of rejection in the first 3, 6, and 12 months. There was no difference in patient survival or graft survival. There were 11 biopsy-proven recurrences (1 man, 10 women) of AIH after OLT. Almost half the episodes occurred within the first year after OLT. No patient required re-OLT because of recurrent disease. AIH has an incidence of 4{\%} and a recurrence rate of 20{\%} in OLT. Transplant recipients are more likely to be young women and have an increased incidence of acute cellular rejection (ACR) during the first post-OLT year. Recurrence should be suspected in those with abnormal liver function test results in the absence of ACR, especially during the first year after OLT. We cannot establish with certainty whether the observed process represents recurrence of the original autoimmune disease, an alloimmune phenomenon, or allograft dysfunction mimicking AIH.",
author = "Molmenti, {Ernesto P.} and Netto, {George J.} and Murray, {Natalie G.} and Smith, {Douglas M.} and Hebe Molmenti and Crippin, {Jeffrey S.} and Hoover, {Tyrone C.} and Ghapjoong Jung and Shigeru Marubashi and Sanchez, {Edmund Q.} and Brian Gogel and Levy, {Marlon F.} and Goldstein, {Robert M.} and Fasola, {Carlos G.} and Gonwa, {Thomas A.} and Klintmalm, {Goran B.}",
year = "2002",
doi = "10.1053/jlts.2002.32981",
language = "English (US)",
volume = "8",
pages = "519--526",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients

AU - Molmenti, Ernesto P.

AU - Netto, George J.

AU - Murray, Natalie G.

AU - Smith, Douglas M.

AU - Molmenti, Hebe

AU - Crippin, Jeffrey S.

AU - Hoover, Tyrone C.

AU - Jung, Ghapjoong

AU - Marubashi, Shigeru

AU - Sanchez, Edmund Q.

AU - Gogel, Brian

AU - Levy, Marlon F.

AU - Goldstein, Robert M.

AU - Fasola, Carlos G.

AU - Gonwa, Thomas A.

AU - Klintmalm, Goran B.

PY - 2002

Y1 - 2002

N2 - We prospectively collected data on 1,429 liver transplant recipients between December 1984 and December 1998. Fifty-five patients (3.8%; 10 men, 45 women; median age, 44.5 ± 13 [SD] years) with autoimmune hepatitis (AIH) underwent orthotopic liver transplantation (OLT). Transplant recipients with AIH were younger, more likely to be women, and had a greater likelihood of rejection in the first 3, 6, and 12 months. There was no difference in patient survival or graft survival. There were 11 biopsy-proven recurrences (1 man, 10 women) of AIH after OLT. Almost half the episodes occurred within the first year after OLT. No patient required re-OLT because of recurrent disease. AIH has an incidence of 4% and a recurrence rate of 20% in OLT. Transplant recipients are more likely to be young women and have an increased incidence of acute cellular rejection (ACR) during the first post-OLT year. Recurrence should be suspected in those with abnormal liver function test results in the absence of ACR, especially during the first year after OLT. We cannot establish with certainty whether the observed process represents recurrence of the original autoimmune disease, an alloimmune phenomenon, or allograft dysfunction mimicking AIH.

AB - We prospectively collected data on 1,429 liver transplant recipients between December 1984 and December 1998. Fifty-five patients (3.8%; 10 men, 45 women; median age, 44.5 ± 13 [SD] years) with autoimmune hepatitis (AIH) underwent orthotopic liver transplantation (OLT). Transplant recipients with AIH were younger, more likely to be women, and had a greater likelihood of rejection in the first 3, 6, and 12 months. There was no difference in patient survival or graft survival. There were 11 biopsy-proven recurrences (1 man, 10 women) of AIH after OLT. Almost half the episodes occurred within the first year after OLT. No patient required re-OLT because of recurrent disease. AIH has an incidence of 4% and a recurrence rate of 20% in OLT. Transplant recipients are more likely to be young women and have an increased incidence of acute cellular rejection (ACR) during the first post-OLT year. Recurrence should be suspected in those with abnormal liver function test results in the absence of ACR, especially during the first year after OLT. We cannot establish with certainty whether the observed process represents recurrence of the original autoimmune disease, an alloimmune phenomenon, or allograft dysfunction mimicking AIH.

UR - http://www.scopus.com/inward/record.url?scp=0036276895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036276895&partnerID=8YFLogxK

U2 - 10.1053/jlts.2002.32981

DO - 10.1053/jlts.2002.32981

M3 - Article

C2 - 12037782

AN - SCOPUS:0036276895

VL - 8

SP - 519

EP - 526

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 6

ER -